Exaggeration is different. It occupies the uncomfortable territory between complete honesty and outright deception. Symptoms may be genuine but overstated. Limitations may be real but presented as more severe than they are in daily life. The claimant may not even regard their account as dishonest. Human beings are rarely objective observers of their own suffering. This creates a challenge for everyone involved in personal injury litigation.
Insurers are understandably concerned about paying claims that overstate the true extent of injury. Claimant solicitors have a duty to advance legitimate cases while ensuring evidence remains accurate. Courts must assess credibility without assuming dishonesty. Expert witnesses are expected to provide independent opinions based on the available evidence rather than advocacy. The difficulty is that medico-legal reporting was never designed as a lie detector.
An expert can assess consistency. They can compare reported symptoms with medical records, treatment history and observed presentation. They can identify discrepancies and alternative explanations. What they cannot usually do is determine with certainty whether a claimant is consciously exaggerating symptoms.
That limitation is sometimes overlooked in public discussions about fraudulent claims.
The role of the expert is not to decide whether a claimant is telling the truth. The role is to evaluate the medical evidence and explain whether the reported symptoms, level of disability and prognosis are clinically plausible. Credibility ultimately remains a matter for the court.
This distinction becomes particularly important in cases involving chronic pain, psychiatric injury and whiplash claims. These conditions often rely heavily on self-reported symptoms. There may be limited objective evidence available to confirm or refute the claimant’s account. The assessment therefore depends upon careful analysis of consistency across the medical records, witness evidence and clinical examination.
Most claimants are neither entirely fraudulent nor entirely objective. They occupy the large middle ground where genuine symptoms, subjective experience and human psychology intersect. That reality makes exaggeration far more difficult to identify than outright fabrication.
The industry’s focus on fraud can sometimes obscure this point. The more significant challenge is often not detecting wholly invented claims. It is assessing the extent to which genuine injuries may be overstated, consciously or otherwise.
This is where high-quality medico-legal evidence becomes indispensable. Independent experts provide a framework for evaluating claims through clinical assessment rather than assumption. Their value lies not in exposing fraud but in helping the court understand the difference between reported symptoms and demonstrable impairment.
As personal injury litigation continues to evolve, the debate should become more sophisticated. Fraud undoubtedly exists and should be addressed where evidence supports such findings. Yet the harder question, and the one that arises far more frequently, concerns exaggeration.
The future credibility of the compensation system may depend less on its ability to identify the occasional fraudulent claimant and more on its ability to assess the far larger group whose cases sit somewhere between complete accuracy and deliberate deception.
